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ABSTRACT:  Candanasava gives significant relief to urinary tract infection. Like other 
Ayurvedic drugs Candanasava might be acting not merely as an urinary antiseptic but also as a 
host-modifying factor, thus rendering the host-urinary tract resistant to infection and making the 
bacterial infection pathogenetically less virulent. 
 
INTRODUCTION 
 
 
The urinary tract infection is the commonest 
clinical condition encountered in urological 
practice.  Chronic renal failure in majority of 
cases particularly in India results from 
improperly managed lower urinary tract 
infection.  It causes pyelonepharitis and 
ultimately ends into chronic renal failure due 
to its progressive trend.  Freedman (1963) 
strongly said that bacterial infection can and 
does cause chronic pyelonephritis 
doubtlessly.  That is  why preventive 
nephrology is now gaining popularity: India 
is a poor and developing country.  Therefore 
search for cheaper, freely available, safe and 
effective drugs to control urinary tract 
infection is worthwhile.  Inadequate 
efficacy, causation of side effects and rapid 
development of resistant strains with the use 
of modern drugs limits their utilization in 
urinary tract infection.  Considering the 
above problem, the present study was 
undertaken to explore the satisfactory and 
safer treatment of urinary tract infection 
with ayurvedic resources.  Upadhyaya and 
Singh (1975) have screened a large number 
of herbal urinary antiseptics in Vitro  for 
their antibacterial efficacy.  They observed 
antibacterial effect in some of these drugs 
viz.  Dhataki, Kuta, Haritaki, Goksuru, 
Usira  etc. We, in continuation, selected a 
popular ayurvedic compound drug 
Candanasava  (a herbal Alcoholic 
formulation) to evaluate its efficacy in cases 
of urinary tract infection. The clinical study 
showed encouraging results. 
 
MATERIALS AND METHOD 
 
40 cases of urinary tract infection were 
selected for this study from University 
Hospital, B.H.U.  The patients complaining 
of burning micturition, dysuria increased 
frequency  of micturition, oliguria, 
microscopic haematuria, pyuria, albuminuria 
and similar other urinary symptoms with or 
without the growth of pathogen on urine 
culture were included in this series.  Each 
case was subjected to detailed clinical 
examination and history taking.  Each 
symptom was recorded and graded 
tentatively for their severity in a four grade 
rating  scale (Table –  1). Routine 
examinations such as B.P., Pulse, respiration 
and temperature were also recorded 
regularly. 
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TABLE 1 
Grade rating scale for measuring the severity of symptoms and urinary findings in cases of 
Urinary Tract Infection 
 
Syptoms  Gradings 
 Burning/Dysuria/Dribbling 
0 – No symptom 
1 – Symptom occasionally during micturition 
2  –  Symptom mild but persist in every 
micturition 
3 – Symptom severe which persist in all phase    
of micturition 
Increased frequently 
0 – No symptom 
1 – 6-10 calls per 24 hours 
2 – 10-15 calls per 24 hours 
3 – More than 15 calls per 24 hours 
Oliguria 
0 – No symptom 
1 – Urine volume 750-1000 ml/24 hours 
2 – Urine volume 500-750 ml/24 hours 
3 – Urine volume below 500 ml/24 hours 
R. B. Cs/Pus cells 
0 – Absent in M/E 
1 – Occasionally in M/E 
2 – Fair in No. M/E 
3 – Fair in No. M/E and colour change of urine 
on gross (naked eye) exam. 
Casts/Albumin 
0 – Absent 
1 - + 
2 - + + 
3 - + + + 
 
 
Laboratory Investigations:  Urine of each 
patient was investigated for routine and 
microscopic examination and culture and 
sensitivity test.  Complete haemogram, renal 
function test in ferms of blood urea and 
serum creatinine and plain X-ray abdomen 
were done in these patients.  Intravenous 
pyelegraphy was also performed whenever 
needed. 
 
The drug and the dosage: Candanasava 
(Sukra-Mehadhikara, Bhai, Rat-8/35-39) 
prepared by Ayurvedic Pharmacy, B. H. U. 
according to Ayurvedic Formulary of India 
was used in this study.  It was used in the 
dose of 40  ml/day in two divided doses, 
after meals, mixed with equal amount of 
water for total duration of 6 weeks and the 
efficacy of treatment was assessed at an 
interval of 2 weeks, on the basis of 
following parameters. 
 
1.  Rating of symptoms 
2.  Rating of urinary findings 
3.  Microbiological findings 
4.  Physical wellbeing including 
physiological changes like Pulse, B. 
P., Respiration and Temperature. 
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RESULTS 
 
In the present study 25 patients were male 
and 15 were female with higher incidence of 
age group between 21-30 years.  Majority of 
patients belonged to lower middle class.   
Most of them were government employees, 
students, house wives and farmers.   
Regarding symptoms, durning micturition 
was predominant one which was present in 
over 90% of cases, rest of the features being 
seen in relatively lesser number of cases.   
During urinalysis 47.5% cases showed pus 
cells, 40% case mild albuminuria, 37.5% 
cases showed R. B. Cs., 15% cases showed 
casts.  The pH of the urine was acidic in 
maximum number of cases.  Only few cases 
had alkaline pH. On urine culture only 
27.5% cases showed growth of different 
pathogens. Blood urea and serum creatinine 
level were found within normal range. 
 
The follow-ups studies indicated a 
significant symptomatic relief as is evident 
in terms of significant favourable shift of the 
grades of severity of selected symptoms of 
urinary tract infection (Table 2). A similar 
shift of grades was observed as regard to 
laboratory findings on urine examination 
which supports the clinical findings (Table 
3).  The repeated urine culture done in these 
cases did not become sterile
 in all cases.   
 
TABLE 2 
Symptomatic improvement in terms of shifts of grades during treatment with candanasava 
in 40 cases of U.T.I. 
 
Symptoms 
INITIALS  FOLLOW-UP 
Grades of 
Severity 
No. of 
cases 
% of 
cases 
15 days % 
of cases 
30 days % 
of cases 
45 days % 
of cases 
Burning  0  0  0.0  11.  36.7  53.3 
  1  13  62.5  47.0  43.3  46.7 
  2  10  25.0  35.5  20.0  0.0 
  3  17  12.5  5.7  0.0  0.0 
Dysuria  0  29  72.5  73.5  86.7  86.7 
  1  10  25.0  26.5  10.0  13.3 
  2  0  0.0  0.0  3.3  0.0 
  3  1  2.5  0.0  0.0  0.0 
Increased frequency  0  27  67.5  73.5  76.7  86.7 
  1  4  10.0  17.6  20.0  13.3 
  2  7  17.5  5.9  3.3  0.0 
  3  2  5.0  3.0  0.0  0.0 
Dribbling  0  31  77.5  82.4  90.0  93.3 
  1  6  15.0  11.8  10.0  6.7 
  2  2  5.0  5.8  0.0  0.0 
  3  1  2.5  0.0  0.0  0.0 
Oliguria  0  32  80.0  82.3  86.7  86.7 
  1  5  12.5  11.4  10.0  13.3 
  2  3  7.5  5.9  3.3  0.0 
  3  0  0.0  0.0  0.0  0.0 
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TABLE 3 
Improvement in urinary analysis with candanacasa in 40 cases of U.T.I. 
 
Urinalysis 
INITIALS  FOLLOW -  UP 
Grades of 
Severity 
No. of 
cases 
% of 
cases 
15 days% 
of cases 
30 days % 
of cases 
45 days % of 
cases 
Albumin  0  24  60.0  82.3  90.0  93.3 
  1  13  32.5  14.3  10.0  6.7 
  2  3  7.5  3.4  0.0  0.0 
  3  0  0.0  0.0  0.0  0.0 
Pus cells  0  21  52.5  70.6  80.0  93.3 
  1  14  35.0  26.5  16.6  6.7 
  2  5  12.5  2.9  3.4  0.0 
  3  0  0.0  0.0  0.0  0.0 
R.B.Cs  0  25  62.5  82.3  86.7  86.7 
  1  11  27.5  14.7  10.0  13.3 
  2  4  10.0  3.0  3.0  0.0 
  3  0  0.0  0.0  0.0  0.0 
Casts  0  34  85.0  88.8  93.3  93.3 
  1  4  10.0  8.9  6.7  6.7 
  2  2  5.0  3.3  0.0  0.0 
  3  0  0.0  0.0  0.0  0.0 
 
DISCUSSION 
 
The present clinical  and laboratory studies 
showed significant symptomatic 
improvement with marked changes in the 
urinary alterations with the use of 
candanasava  in cases of urinary tract 
infection. Through the urine cultures did not 
become negative within six weeks of 
therapy, pus cells, R. B. Cs, casts and 
albumen almost disappeared in all the cases.  
It is possible that the clinical relief reported 
by the patients and urinary alternations 
found out by the laboratory investigations, 
were more due to some other unknown 
mechanism. 
 
One of them may be that the drug may 
produce soothing effect on local mucosa of 
the urinary tract which might be producing 
relief of symptoms like burning sensation, 
dysuria etc. Such an influence of the drug 
may be attributed to its ingredients specially 
the  candana (Santalum album Linn), 
Mustaka (Cyperus rotundus), Gambhari 
(Gmelina arborca), Padmakastha (Prunus 
cerasoides), Patha (Cissampelos pareira), 
Patola (Trichosanthes dioica), Dhataki 
(Woodfordia fruticosa) etc.  These are 
potent drugs.  In Ayurvedic literature 
candana has the property of Mutramarga – 
Kotha – Parsaman (antiseptic).  Mustaka 
is Kandughna and Mutrala  (Anti- puritic 
and diuretic), Gambhari  is  Sotha-hara 
(Anti-inflammatory).  Padmakastha  is 
Vedana sthapana (analgesic).  Patha  and 
Patola  are also Sotha-hara  and  Mutra 
Krochra-hara  (Anti-inflammatory) and 
Dhataki is Mutra Viranjaniya (altering the 
colour of urine).  Secondly, various 
ingredients of drug might be, on the other 
hand, influencing the chemical composition 
of the urine in such a way that the symptoms 
like burning, dysuria etc, are reduced and Pages 248-252 
the local condition for growth of the 
pathogenic organism become less 
flavourable leading in turn to the control of 
infection.  Thirdly, these drugs might be 
producing fundamental changes in the host 
as well as the parasite organisms in terms of 
Prakrti-Vighata as conceived by the great 
Ayurvedic physician Charaka.  All these 
hypothetical concepts need further 
experimental support  
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